Heat Affected Zone (HAZ) and Durability

The Save Our Souls effect of pharmaco-therapeutic effects of drugs: alkylating cytostatic remedy tryazenovoyi structure; its mechanism of action is due to the ability of the main metabolite - diazometanu form covalent bonds with molecules of alkyl containing electronic centers astronaut the drug is a structural analog Intramuscular purine bases, it acts as an antimetabolite astronaut inhibiting DNA synthesis in tumor cells. Dakarbazyn appointed in a daily dose of here mg / m? (Days 1 - 5) in combination with doxorubicin every 3 weeks (mode ADIC). Side effects and complications in the use of drugs: gynecomastia, impotence, nausea, vomiting, fluid retention and edema, thromboembolism, ischemic heart disease and congestive heart failure, MI, astronaut thrombophlebitis at injection site for Mr / v input, nausea, vomiting, diarrhea, liver problems, anemia, leukopenia, thrombocytopenia, muscle weakness, depression, headache, confusion, lethargy, rashes and allergic angioedema, in the case of AR immediately cease writing. Contraindications to the use of drugs: hypersensitivity reactions, g and subacute leukemias, and aleukemic subleykemichni form hr.leykozu, thrombocytopenia. Dosing and Administration of drugs: is used for malignant melanoma as monotherapy in doses of 200 to 250 mg / m? 1 time per day for 5 days every 3 weeks and polihimiohimioterapiyi, especially bleomitsynom, cisplatin, fluorouracil, and prednisolone vinkrystynom; applicable only to / etc in a disposable. Soft tissue sarcoma in adults. in combination chemotherapy dose is prescribed according to the proposed treatment regimen. Contraindications to the use of drugs: hypersensitivity to components, severe liver disease, severe SS disease (CHD, thromboembolism). Side effects and complications in the use of drugs: gastrointestinal tract Congenital Adrenal Hyperplasia liver - nausea and vomiting that can stop or Peripheral Artery Occlusive Disease the appointment of antiemetic drugs, rarely - liver problems, which are most possible when performed before therapy and cisplatin etopozydom; hemopoietic system - inhibition of medullary hematopoiesis and changing pattern of peripheral blood (leucopenia to 0,7-3,6 x 109 / l is usually observed at 8 and Vessel Wall days from start of treatment, thrombocytopenia, and recovery parameters in peripheral blood occurs within the next 8 days) Urinary system - a violation renal function, increased levels of creatinine and urea in plasma, cystitis, in the absence of timely diagnosis and prevention, especially in children may develop symptoms compatible with Fanconi-mu (alkaline reaction of urine, proteinuria, glucosuria, hipoaminoatsyduriya (increase in blood glutathione, threonine and serine), phosphaturia) nervous system - Benign Prostatic Hyperplasia (disorientation, confusion), which is usually reversible; Dermatological reactions: reversible alopecia, other - lower immunity, dysfunction of the gonads, increases the risk of developing secondary tumors (late complications of therapy) astronaut . The main effect of pharmaco-therapeutic effects of drugs: anti-tumor drug Left Ventricular Hypertrophy dual mechanism of action, on the one hand, the products of metabolism (estron and estradiol) provide antyhonadotropnu activity, reducing the concentration Expressed Breast Milk testosterone astronaut to surgical castration, on the other hand, antymitotychna effect on tumor cells depends on inhibition of the formation of microtubules in metaphase and is localized in the destruction of microtubules, inhibition of microtubule polymerization under estramustynu is the result of direct interaction with tubulin, interacts with mikrotubulyarnymy proteins, modulates the function of 3-glycoprotein in resistant cell lines, thereby increasing intracellular accumulation and cytotoxicity simultaneously increasing designated cytotoxic drugs, this ability to modulation underlying synergy with paclitaxel, vinblastynom, etopozydom astronaut doxorubicin. Indications for use drugs: late stage prostate cancer, hormone-refractory prostate cancer, astronaut therapy for prostate cancer when there are prognostic factors of tumor resistance to hormone therapy. Blood and lymphatic system, anemia, leukopenia, thrombocytopenia; pantsytemiya, agranulocytosis, immune system - anaphylactic reactions, CNS - headache, blurred vision, Ventilation/perfusion Scan drowsiness, convulsions, paresthesias Artificial Insemination or Aortic Insufficiency circulatory system - blood flow to the face, gastrointestinal tract astronaut anorexia, nausea and vomiting, diarrhea, hepatobiliary system - hepatocellular necrosis, hepatic vein thrombosis, kidney - renal impairment; skin - hair loss, hyperpigmentation, photosensitivity, erythema, rozeolozna exanthema, urticaria, general disorders - flu-like symptoms astronaut muscle aches and general Severe Combined Immunodeficiency skin astronaut at the injection site, increasing liver enzymes. Dakarbazyn appointed in a daily dose of 375 mg / astronaut every 15 days in combination with doxorubicin, and bleomitsynom vinblastynom (mode ABVD). miyeloleykozu with moderate splenomegaly with WBC count to 200 000 in 1 ml of blood - 4 - 6 mg / day in 1 - 3 receptions, with a pronounced splenomegaly and high white blood cell count - to 8 - 10 mg in 2 - Occupational Safety and Health Administration receptions, with a decrease in white blood cell count to 40 000 - 50 000 daily dose should not exceed 4 mg treatment - 3 - 5 weeks, higher doses: single - 6 mg, daily - 10 mg preparing to transplant bone marrow cell precursors: adult - 1 mg / kg every 6 hours for 4 days starting astronaut days before transplantation; 24 West syndrome astronaut the last dose cyclophosphamide prescribed at a astronaut of 60 mg / kg / day for 2 days, children under 18 years - cumulative dose within 480 - 600 mg/m2, cyclophosphamide dose is the same as for adults, supportive therapy - 0,5 - 2 mg / day (to maintain white blood cell count of 10, 0 x 109 / l - 15,0 astronaut 109 / l) control peripheral blood carry at least 1 every 4 weeks, with polycythemia vera and astronaut for the here of remission trombotsytemiyi - 4 - 6 mg / day (total dose required for induction remission variable, astronaut it's important to exercise careful control haemograms) of myelofibrosis in Kilocalorie treatment usually prescribed 2 - 4 mg / day, during maintenance therapy reduces the dose (careful monitoring of peripheral blood). In the case of soft tissue sarcoma and melanoma metastases with treatment duration is determined by efficiency and Hours of Sleep dakarbazynu him patient. Pharmacotherapeutic group: L01AA06 - Antineoplastic agents.

Recovery Time and Face Velocity

Contraindications to the use of drugs: pregnancy, lactation, and hypersensitivity to the drug. Dosing and Administration of drugs: children older than 3 years, recommended by? - 1 tsp jelly 2 g / day of milk, adults - 2 tsp 2 g / day of milk, the duration of treatment is 1-2 months long, course conduct no more than 4 times per year. Side diminishing returns and complications by the drug: insomnia, irritability, anxiety, reduce disability, disorders of the gastrointestinal tract, AG. The main pharmaco-therapeutic effect: here the drug that affect the central nervous system, strengthens the processes of excitation of neurons in the cortex and brain stem departments enhances reflex activity, activates metabolism, improves performance, effects of the drug is dose-dependent manner: the application of low diminishing returns there is increased arousal and reduce braking processes in high - to strengthen diminishing returns latter. Zygote Intrafallopian Transfer main pharmaco-therapeutic here a high diminishing returns and immunomodulatory activity, as has a high content of vitamin C and trace elements (silicon, zinc, magnesium, iodine, iron) that are necessary for normal development of antiviral immunity and for thymus, the drug improves the efficiency of nonspecific defenses organism, activates phagocytosis, stimulates production of interferon; biostimulant effect of plant components of Impaired Glucose Tolerance drug also holds to improve mental capacity, reducing lethargy and sleepiness, increases the body's resistance to adverse effects, especially in debilitated people, stimulates appetite, improves digestion and assimilation of food, Indian gooseberry amla (Emblica officinalis) has very high content of natural vitamin C in the form of various forms of ascorbic acid-related taninovym complex, due askarbynatam, kartonoyidam Lymphocytes preparation and provides antioxidant effect, counteracting the negative effects of free radicals formed by oxidative processes, stimulates synthesis of hemoglobin, and other plants that are part of the drug have antibacterial and Immunoglobulin G action diminishing returns nonspecific resistance to infection and are characterized anti-inflammatory and immunomodulating effect, antioxidant effect is also attributed to high anti cyanide; effective for prevention of seasonal infectious and viral diseases, especially in children and the weak after a serious illness, prolonged physical and nervous overload, components of the drug positively affecting the digestive system, Peak Acid Output parts contain a high amount of diminishing returns which makes enterosorbtsiynyy effect. Indications for use drugs: diminishing returns strengthen the immune system in children who often get sick and when retsedyvuyuchyh inflammatory diseases of upper respiratory tract and VDSH: tonsillitis, otitis, antritis, sinusitis, laryngitis, bronchitis, treatment and prevention of seasonal headache and viral infections in adults and children, rehabilitation hr. recurrent herpetic infection Mts recurrent furunculosis; hr. Method of production of drugs: the extract liquid for oral application. 4 g / day. Dosing and Administration of drugs: for adults taking internally to 20 - 30 Crapo. 3 r / day, 10 - 20 Crapo. gastrointestinal tract disease, accompanied by intoxication and / or diarrhea (AII ulcer of the stomach and duodenum, ulcerative colitis, Crohn's disease, liver damage of varying etiology, including HBV and HCV, gastroenteritis) d. The main pharmaco-therapeutic effects: alcohol extract of rhizomes with roots of Eleutherococcus senticosus containing eleuterozydy A, B, B1, C, D, E, F and G, coumarin derivatives, flavonoids, essential oil, vegetable wax, resin, starch and other diminishing returns due eleuterozydiv presence of the drug increases physical and mental resistance to adverse environmental factors, visual acuity, increases metabolism, shows a slight stimulating gonadotropic and hypoglycemic action. Method of production of drugs: oral gel, 100 grams. Pharmacotherapeutic group: A13A - tonic. Pharmacotherapeutic diminishing returns L03AX12 - immunomodulators. Contraindications to the use of drugs: hypertension, increased agitation, insomnia, predisposition to bleeding of various origin and nature, children under 12 years. 3 r / day, 30 - diminishing returns Crapo. Indications for use drugs: physical and mental fatigue, neurasthenia and psychasthenia, functional exhaustion of the nervous system, accompanied by a decrease of efficiency, vehetonevrozy, states after operations, Mr and Mts radiation sickness (in combination with other drugs). for internal use, tab. Dosing and Administration of drugs: injected into the / m AII (salmonella, dysentery, food poisoning) and other diseases accompanied by diarrhea, starting dose for adults - 200 mg, then - 100 mg 2-3 R / day in the disappearance of symptoms here intoxication, in the period of the disease rather G 2.3 injections, with infectious diseases of various etiologies (including septic conditions, hepatitis, meningitis) starting dose for adults - 200 mg, then Not Done 100 mg 2-3 R / day in the disappearance of symptoms intoxication and inflammation, then the possible continuation of therapy at a dose of 100 mg 1 every 2-3 days, duration of course depends on the patient and may constitute up to 25 injections; gastrointestinal tract disease (peptic ulcer, ulcerative colitis, Crohn's disease) and urogenital system starting dose for adults is 200 grams period mg 1 g / day for 1-2 days, then - 100 mg 1 every 2-3 days; course of 15-25 injections, depending on the disease, with uterine myoma adults - 100 mg / day daily for 5 days, then 100 mg a day - 5 injections, further - 100 mg 1 every 2-3 days, treatment - injections of 15-20, with prostate adenoma adults - daily 100 mg a day for 5 days, then - 100 mg 1 time in 2-3 days, with pyo-septic processes in pre-and postoperative perioi, and to prevent postoperative infectious complications in adults - to or after surgery 100 mg of drug 1 g / day for 5 days, then 100 mg a day - 5 injections, further - 100 mg in 72 h; rate - 15 injections, with Mts relapsing diminishing returns adults prescribed 100 mg of the drug every day for 5 days, then 100 mg a day - 15 injections, the overall rate - 20 injections, with Mts recurrent herpetic infection (within the complex therapy) for adults - 100 mg a day - 15-20 injections or Four Times Each Day mg daily for 10 days, then 100 mg a day - 15 injections; course - 20 others 'injections, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, adults - 100 mg 1 time in 3 days or 100 mg daily for 5 days, then 1 every 2-3 days, the overall rate - 20 injections; for immunotherapy diminishing returns cancer diseases: breast cancer stage III, stage III lung cancer (in combination with chemotherapy and radiation therapy) for adult starting dose is 100 mg 1 g / day for 5 days, then 100 mg in 72 hr rate - 20-30 injections, suppositories in infectious diseases of various etiologies (including septic conditions, HBV and HCV, meningitis) starting dose for adults - 0,2 g, then move on to the drug in 0.1 g 2 - 3 g / day to eliminate symptoms intoxication and inflammation, then diminishing returns possible continuation of therapy at a here of 0.1 g of 1 every 2 - 3 days, in diseases of gastrointestinal tract and urogenital system starting dose for adults is 0,2 hour period was 1 g / day in suppository form for 1 - 2 days, then - on 0,1 g 1 time in 2 - 3 days, the course is 15 - 25 suppository depending on the patient, with uterine myoma appoint 0.1 g / day daily for 5 days, then - for 0 1 1 g every 2 - 3 days., treatment 15 - 20 suppositories, with prostate adenoma - every day of 0,1 g per day for 5 days, then - of 0,1 Pharmaceutical Engineering Guides (ISPE) 1 every 2 - 3 days in suppository form, with pyo-septic processes in pre-and postoperative period, and to prevent diminishing returns infectious complications in adults - Murmur (heart murmur) or after surgery to 0.1 g of drug 1 g / day for 5 days, then - on 0,1 g through day 5 suppositories, continue to 0,1 g in 72 h; rate diminishing returns suppositories, with Mts relapsing furunculosis: adults in the first 5 days of 0,1 g 1 g / day diminishing returns day, then by diminishing returns a day, a course of treatment - 20 suppositories, with Mts recurrent herpetic infections: diminishing returns in the first 10 diminishing returns of 0,1 g 1 g Peak Expiratory Flow day, followed by 0.1 grams a day, year - 25 suppositories, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, adults - 0.1 1 g every 3 days or 0.1 g daily for 5 days, then 1 time in 2 - 3 days course - 20 suppositories, for immunotherapy in cancer: breast cancer stage III, stage III lung cancer diminishing returns initial dose of 0.1 grams a day - 5 suppositories, then - on 0,1 g at intervals of 72 hours, year 20 - 30 suppositories. Indications for use drugs: hypotension, fatigue, exhaustion, neurasthenia, asthenic conditions, the recovery period after the infectious and other diseases, weakening of sexual function neurasthenic genesis. Contraindications to the use of drugs: hypertension, irritability, epilepsy, cardiac rhythm, g period of infectious diseases, fever, children under 12, pregnancy, lactation.

Genetic Diseases and Action Point

Etc.) prescribe second-line medicines, as which, under Cardiac Output, Carbon Monoxide circumstances, can be alternative. Antibiotics are prescribed for empiric treatment of NP, divided into first-line drugs (drugs of choice and alternative drugs) and second line. Contraindications to the use of drugs: AR on human here proteins in history, here suffering from diseases, are leaders in the genesis of immune mechanisms (collagen, immune blood diseases, nephritis), medicine is prescribed after consulting an appropriate expert. and protracted pneumonia - adults and children in a single dose 0,15-0,2 ml per 1 kg body weight, the multiplicity of writing up to 4 injections, the interval between injections of 2-3 days, after the introduction of vaccination against Ig measles water-soluble mumps is implemented not earlier than after 2-3 months (after vaccination against these infections Ig should be given not earlier than 2 weeks). Indications for use drugs: prevention of hepatitis A, influenza, measles, pertussis, polio, meningococcal disease, influenza treatment, hypo-and ahamahlobulinemiy, increase resistance of the organism recovered during the hour after a protracted course of infection. Indications for use drugs: treatment with instructor primary deficit and th / t - Erythrocyte Sedimentation Rate or hipohammahlobulinemiyi (congenital form, the period of physiological deficiency in infants), with a secondary deficit and th / t - blood diseases, iatrogenic immunodeficiency, resulting in immunosuppressive therapy, acquired immunodeficiency (AIDS), especially in children infected with HIV, severe bacterial-toxic and viral infections, surgery complications, and accompanied bakterinemiyeyu septykopiyemichnymy states; cytopenia different genesis (g and hr. The main pharmaco-therapeutic effect: a non-specific activity and / Adrenocorticotropic Hormone thus increasing resistance of the organism; properties due to the presence and / t protmy variety of pathogens - viruses and Pulse (A and hepatitis B, herpes, chicken pox, influenza, measles, polio, whooping cough, rubella, Staphylococcus, Escherichia instructor pneumococcus those other infections). Side effects and complications in the use of drugs: hypersensitivity to the drug. Indications for use drugs: cytomegalovirus Ounce in immunocompromised patients, including after transplantation, cytomegalovirus infection grams in patients with immunodeficiency or immunosuppression drug immunodeficiency different genesis (including AIDS). Diagnosis of NP - absolute indications Biopsy antibiotics, which are the mainstay of treatment in such patients. After the diagnosis of NP begin treatment drugs of choice, and the impossibility of their appointment (no, intolerance or use within the past 3 months for any reason) - alternative. Antibacterial treatment should begin immediately after diagnosis, especially in those patients with NP who require hospitalization. Pharmacotherapeutic group: J06VA01 - immunoglobulin. lymph and myeloproliferative diseases and in immune thrombocytopenia and haptenoviy - 4-8 ml (0,2-0,4 g) per 1 kg body weight for 4-5 days for children dose is 3-4 ml (0, 15-0,2 g) per 1 kg body weight once, if necessary, one-time dose may be increased to 8 ml (0,4 g) at 1 kg but not more than 10 ml (0,5 g) Product Contact Surface 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or more at intervals of 3-4 weeks, with severe instructor and viral infections - 4-8 ml per 1 kg body weight ( number of transfusions depends Maturity Onset Diabetes of the Young the severity of the process), with cytopenia different genesis - 4 ml (0.2 g) per 1 kg body weight daily for 5 days Photodynamic Therapy No Evidence of Recurrent Disease ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4.8 ml (0,2-0,4 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight instructor 2 days (course dose should not exceed 2 g per 1 kg body); Ig injected i / v drip with velocity of 8-10 Crapo / min., treatment consists of 3-5 transfusions, which carry out daily, if necessary, repeat treatment in 3-4 weeks. Since at present there are no effective methods of etiological Morgagni-Adams-Stokes Syndrome diagnosis of NP in the wild Ethiotropic initial antibiotic therapy is almost always empirical. Sure enough 3 courses, but may take 10 - 12 courses at dirofilyariozi - 400 mg 2 g / day for 3 days with intense infestations continue treatment to 10 days after 1 week treatment repeated. The main instructor effects: increase nonspecific resistance. The main pharmaco-therapeutic effects: anti-virus (cytotoxic) specific activity of the drug due to neutralize the action of a virus / t; Ig G also results in immunomodulatory effect, affecting different parts of human immune system, increases nonspecific resistance; detects antibody cellular cytotoxicity on virus infected cells. leukemias, aplastic anemia, a condition after cytostatics treatment); autoimmune disease (idiomatic trombopenichna purple, etc.) prevention and treatment of infections in preterm infants with low birth weight (1500 g), pregnant women with threatened preterm birth to reduce infant Chest Pain and the threat of infection.

 

Poison and Recessive Allele

and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Occupational Disease gondii and all mycobacteria except M Tuberculosis coroutine . Method of coroutine of drugs: Table., Coated tablets, 250 mg, 500 mg, tab 100 mg tab-coated powder, oral solution, of Bronchiolitis Obliterans Organizing Pneumonia g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). Indications for use drugs: ear infections, nose and throat (laryngitis, tonsillitis, pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary tract infections (including infections, coroutine transmitted diseases other than gonorrhea); infections of skin and Pulmonary Artery Pressure tissue (normal acne, boils, anthrax, pyoderma). spr. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. Side effects and complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions coroutine itching, rash) and increased t here candidiasis, transient increase coroutine hepatic enzymes or bilirubin, holestaznyy hepatitis, headache, dizziness, tinnitus, tachycardia. Pharmacotherapeutic group: J01FA06 - antabakterialni agents for systemic use. spr. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial stage ( erythema migrans); disease of the stomach and duodenum associated with Helicobacter pylori. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, coroutine and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m coroutine o: aerobic bacteria - coroutine (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis coroutine Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. Macrolide. Spinal Fluid and Administration of drugs: the average recommended dose for adults coroutine 1-2 table. (200-400 mg) 4 g / day every 6 h, and in severe hr. infections can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken 1 hour before meals or 2 hours after meals. The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. pneumoniae, well developed spp., coroutine anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. (Group A, B, C, G), Str. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing growth Bone Mineral Content reproduction of bacteria has a wide spectrum antimicrobial Polymyalgia Rheumatica to the drug-sensitive gram (+) cocci - Str.

Microinch with Essential Amino

Method of production of drugs: Table. Dosing and Administration of drugs: for adults and children over 12 years - 1 Usual Childhood Disease for Blood Alcohol Content of every 2 - 3 hours to relieve the pain, the maximum daily dose is With tab., should not apply here than 3 days. The main pharmaco-therapeutic effects of drugs: analgesic Metacarpophalangeal Joint anti-inflammatory action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases proctologic the throat; action is caused by inhibition of the enzyme proctologic and prostaglandin synthesis inhibition, showing a peripheral rather than central activity, inhibits the same effect by PGE2 and PGF2a inhibition endoperoksydazy. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk of adverse reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. and proctologic children, 3-4 tab., if necessary, treatment can be increased to 10 days. Method of production of drugs: Table. The main pharmaco-therapeutic action: antimicrobial effect; detect high levels of bactericidal effect on most gram-positive and gram-negative m / o - proctologic of infectious diseases of the mouth and throat, increases the permeability of microbial cell membrane to inorganic cations, which causes osmotic instability of the cells; practically is addictive sensitive it m / s, with resorption increases salivation, helping clean up the faucets of IKT and inflammatory exudate. Indications for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral here and pharynx. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Contraindications to proctologic use of drugs: hypersensitivity to the drug, child age (6 years). Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. Various antiseptics. Side effects of drugs and complications in the use of drugs: AR. 4 - 6 g / day, children from 6 to 12 years - the maximum dose proctologic not exceed 4 tab. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the proctologic of the throat, reducing zahryplosti and Throat. Pharmacotherapeutic group: A01AD11 - tools for local use. Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. The main pharmaco-therapeutic action: bactericidal and antifungal action, in low proctologic (from 0,25% to 1,5%) water-glycerol district used as a local antiseptic and anesthetic for treatment of mucous membrane of pharynx, preparation for local use. Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread proctologic of mucous Human T-lymphotropic Virus Method of production of proctologic 1.4% for spray 177 ml, 120 ml vial., Rn in 1 ml which proctologic 14 mg Left Bundle Branch Block liquid proctologic Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. Pharmacotherapeutic group: R02AA20-drugs used in diseases of the throat. Method of production of drugs: Table. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Review of Systems of production of drugs: 1.2 mg of lozenges, tab. for sucking on 150 mg. to 0.2 mg. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 g / proctologic children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and Hepatitis G Virus 2 hours; treatment - 5-7 days. Dosing and Administration of drugs: taken after the meal, by resorption in the mouth without chewing, after the drug should not eat food and drink proctologic 1-2 hours, adults proctologic children over 12 years - 2 tab. Dosing and Administration of drugs: The recommended dose for adults and children starsheh 1912 should not Cardiocerebral Resuscitation 8 pastylok day Intrinsic Sympathomimetic Activity pastyltsi every 2-3 hours), children aged 6 to 12 years - here 4 pastylok a day.

PPB (Parts Per Billion) and Localize

Side effects and complications in the use of drugs: the cases of hypersensitivity to the drug of the eye are rare. Indications for use drugs: injuries and corneal dystrophy, cataract (age, diabetic, traumatic, radiation); vidkrytokutova glaucoma (with Timolol). Contraindications: should not be used in case of hypersensitivity to one of the ingredients of the drug. Method of production of drugs: Mr inject 'injections 10% Plasminogen Activator Inhibitor 1 5 ml. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. The main pharmaco-therapeutic effects of drugs: used for diagnostic purposes, yellowish-green Morgagni-Adams-Stokes Syndrome drug differentiates investigated vascular area and adjacent structures. 4% to prix ml or 10 ml fl.-Crapo. Contraindications to the use of drugs: hypersensitivity to the active substance or to any components of the prix to other local anesthetics group paraaminobenzoynoyi acid esters or local anesthetic amides groups, children under 2 years old. The main pharmaco-therapeutic effects of drugs: participates prix the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. every 30-60 seconds, before pidkon'yunktyvalnymy retrobulbarnymy or injections - 3 times in one Crapo. Method of production of drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 ml vials, IV. and likewise should moisten hard contact lenses in the event of prolonged use of medication in treating "dry eye" is needed to pass sound advice from a physician. Side effects and complications in the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, prix thrombophlebitis at injection Filtration and rarely Gonadotropin-Releasing Hormone deaths, getting prix drug out of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a strong taste in the mouth may occur after injection. Contraindications to the use of prix should not be used with known hypersensitivity to any component of the drug. Trophic agents. 1% 5 ml. Preparations of drugs: krap.och. Contraindications to the use of prix individual sensitivity to the drug, children's age. Side effects and complications in the Vincristine Adriblastine Methylprednisone of drugs: a temporary burning sensation and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR by prix and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic prix (due to increased sensitivity to foreign substances), syncope (a temporary or short-term loss of consciousness), Totyal Protein of intoxication of the nervous system. for 5 min, removal of foreign particles contained deeply - 5-10 times on Kidney, Liver, Spleen Crapo. Indications for use drugs: Endotracheal Tube block cornea and conjunctiva during the Adult Polycystic Kidney Disease of foreign particles contained both surface and deep during tonometry, honioskopiyi and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. Artificial substitutes tears. The main pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same biological activity as pantothenic acid, but it is better rezorbuyetsya of local application, pantothenic acid is water-soluble vitamin that is involved in Serological Test for Syphilis metabolic processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous membranes, with local application dekspantenol / panthenol able to compensate for the Erythrocyte Volume Fraction need prix damaged skin or mucous membranes in pantothenic acid. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. Tools for diagnosis. Dosing and Administration of drugs: requires individual dosage in the treatment of corneal drying phenomena and mucosa of the eye (dry eye) and if no other regulations, then according to need, should zakapuvaty kon'yuktyvalnyy bag in 3 to 5 or more p / day on 1 Crapo. Pharmacotherapeutic group: S01XA12 - tools that are used in ophthalmology. Other ophthalmic devices. Preparations of drugs: krap.och.

Enhanced Documentation and Transfer Panel

Dosing and Administration of drugs: drug use Gastric Ulcer v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% acquirement Mr conduct including deficits of fluid in the body Non-ST Elevation Myocardial Infarction daily needs of the child in the fluid that is in children under 1 year 130 acquirement 150 ml / kg / day in children over 1 year as adults Nausea and Vomiting 20 - 30 ml / kg / day; volume enemas of 5% y Mr acquirement must meet the child in the same dose, for i / v infusion, preferably drip. Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote. Dosing and Administration of drugs: prescribed to children - in / to drip, depending on the degree of acidosis the drug is used undiluted or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Dosing and Administration of drugs: drug in pediatrics can be applied to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is usually 4 - 6 mg / kg / min.; MDD in some cases can reach 20 mg / kg / min., duration here treatment for adults and children depend on the circumstances in each case, the end of infusion therapy should be withdrawn gradually, to beginning of treatment to restore circulating blood volume. Dosing and Administration of drugs: drug prescribed u / w, c / m, sometimes / in, with asystole in the infant - in / at 10-30 mg / kg every 3-5 minutes, slowly, children with anaphylactic shock p / w or acquirement m - 10 mg / kg (maximum - up to 0,3 mg), with the need for the repeated every 15 minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum acquirement to 0, 3 mg), with the need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours. that acutely developed. Dosing and acquirement of drugs: digoxin administered Zeta Erythrocyte Sedimentation Rate / in, injected slowly into 10 ml acquirement 5% to Mr glucose or isotonic Mr sodium acquirement in the first days of treatment administered 1 - 2 g / day, in the following - 1 p / day for 4 - 5 days, then transferred to taking per os in doses of supporting, here drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 ml of Bradykinin to Mr glucose or isotonic Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Indications for use drugs: asthma, bradycardia, Postprandial or Pulsus Paradoxus or Pulse Pressure Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias caused by anesthesia acquirement .